BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bibeau F, Chateau MC, Guiu M, Assenat E, Azria D, Lavaill R, Ychou M, Boissière-Michot F. Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour. Virchows Arch 2008;452:103-7. [PMID: 18008084 DOI: 10.1007/s00428-007-0533-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol 2012; 18(13): 1545-1551 [PMID: 22509088 DOI: 10.3748/wjg.v18.i13.1545] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
2 Hirabayashi K, Zamboni G, Nishi T, Tanaka A, Kajiwara H, Nakamura N. Histopathology of gastrointestinal neuroendocrine neoplasms. Front Oncol 2013;3:2. [PMID: 23346552 DOI: 10.3389/fonc.2013.00002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
3 Al Mansoor S, Ziske C, Schmidt-Wolf IG. Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature. Ger Med Sci. 2013;11:Doc12. [PMID: 23983673 DOI: 10.3205/000180] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
4 Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther. 2015;8:437-444. [PMID: 25709477 DOI: 10.2147/ott.s76048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
5 Schizas D, Michalinos A, Alexandrou P, Moris D, Baliou E, Tsilimigras D, Throupis T, Liakakos T. A unique tripartite collision tumor of the esophagus: A case report. Medicine (Baltimore). 2017;96:e8784. [PMID: 29245236 DOI: 10.1097/md.0000000000008784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Kinoshita T, Ishikawa S, Inaba T, Sakakihara I, Izumikawa K, Takahashi S, Yamamoto K, Tanaka S, Wato M, Nakamura S, Yao T. Neuroendocrine carcinoma arising from Barrett's esophageal adenocarcinoma: a case report. Clin J Gastroenterol 2020;13:1028-35. [PMID: 32852724 DOI: 10.1007/s12328-020-01210-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tustumi F, Takeda FR, Uema RH, Pereira GL, Sallum RA, Cecconello I. Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4-10. [PMID: 28079231 DOI: 10.1590/s0004-2803.2017v54n1-01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
8 Trembath DG, Shaheen NJ, O'Neill S, Weck K, Greene KG. Metastatic melanoma in an esophagus demonstrating Barrett esophagus with high grade dysplasia. BMC Res Notes 2013;6:457. [PMID: 24220097 DOI: 10.1186/1756-0500-6-457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Doi S, Matsumoto S, Wakatsuki K, Migita K, Ito M, Kunishige T, Nakade H, Hatakeyama K, Ohbayashi C, Sho M. A neuroendocrine carcinoma with a well-differentiated adenocarcinoma component arising in Barrett's esophagus: a case report and literature review. Surg Case Rep 2018;4:103. [PMID: 30159830 DOI: 10.1186/s40792-018-0511-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yan J, Liu W, Wang X, Zhao S, Gao L, Ye Y, Lei X, Long Y, Ji J, Zhang W. Primary Central Nervous System Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Colliding with Meningioma. World Neurosurg 2018;120:17-26. [PMID: 30144614 DOI: 10.1016/j.wneu.2018.08.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A, Faggiano A; NIKE. A rare rarity: Neuroendocrine tumor of the esophagus. Crit Rev Oncol Hematol 2019;137:92-107. [PMID: 31014519 DOI: 10.1016/j.critrevonc.2019.02.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Hiraki M, Tanaka M, Sato S, Kai K, Morito K, Kobayashi K, Noshiro H, Tokunaga O, Miyazaki K. A complete response in small cell carcinoma of the esophagus treated by s-1/cisplatin combined chemotherapy and radiotherapy. J Gastrointest Cancer 2010;41:275-80. [PMID: 20437111 DOI: 10.1007/s12029-010-9159-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, Sun Q, Yang J, Huang L, Ye Q. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37:467-483. [PMID: 23426118 DOI: 10.1097/PAS.0b013e31826d2639] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]